By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Warnex today said that it has signed an agreement to serve as exclusive distributor of 10 of DeCode Genetics' tests in Canada.

Most of the DNA-based tests are for assessing risk of developing certain diseases. The tests will be sold by the Warnex Medical Laboratories division of the Laval, Quebec-based firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.